Patents by Inventor Timothy L. Ruchti

Timothy L. Ruchti has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20160139043
    Abstract: A synthetic projection system determines analyte concentration, such as blood glucose concentration, from a spectral-energy change associated with an uncharacterized instance of a medium in which the analyte is likely present. The projection system is factory calibrated for different instances of the medium, without needing instance-specific training or calibration. The projection system includes a set of projector curves, each relating spectral-energy change values obtained by analyzing reference medium samples to analyte concentrations in those samples. Each projector curve also corresponds to a respective range of energy-change gradients, determined using a group of surrogate media characterized according to analyte concentrations measured using a reference system. A spectral-energy-change gradient for the uncharacterized medium may be computed to select one of the projectors curves.
    Type: Application
    Filed: January 12, 2016
    Publication date: May 19, 2016
    Inventors: Sandeep Gulati, Timothy L. Ruchti, William Van Antwerp, John L. Smith
  • Publication number: 20160139045
    Abstract: In a noninvasive system for detection/measurement of glucose and other analytes in a medium such as tissue, spectra from the medium are deconstructed into features. Conditioned features, which contain frequency components specific to glucose or the other analytes, are derived from one or more features by modulating a carrier kernel with the feature. The conditioned features are computationally collided with one or more Zyotons that are co-dependent with the conditioned features. One or more collisions amplify a property of the analyte e.g., energy absorbed by glucose in tissue from radiation directed to the skin. A gradient of several values of the amplified property, each value corresponding to a particular radiation pattern according to a spectroscopic tomographic sequence, is used to select a suitable projector curve, with which a representative amplified value is projected to an accurate estimate of the concentration of glucose or the other analytes, without needing personalized calibration.
    Type: Application
    Filed: January 12, 2016
    Publication date: May 19, 2016
    Inventors: Sandeep Gulati, Timothy L. Ruchti, William Van Antwerp, John L. Smith
  • Publication number: 20160103960
    Abstract: This disclosure describes systems and methods for a graphical interface including a graphical representation of medical data. The graphical interface platform may receive medical data and provide medical safety reporting capabilities including reporting of history data and real-time visual monitoring data. The graphical interface platform may be configured to identify potential problems and corrections to medical devices in operation while a reporting cycle is underway through visual representation of performance metrics.
    Type: Application
    Filed: December 17, 2015
    Publication date: April 14, 2016
    Inventors: James A. Hume, Robert Mayer, Devy Amy Lee, Gabriele Christensen, Candida Arvelo, Timothy L. Ruchti, Tamas Ban, Mohammad M. Khair, Nancy G. Hedlund
  • Publication number: 20160097716
    Abstract: In a noninvasive system for detection/measurement of glucose and other analytes in a medium such as tissue, spectra from the medium are deconstructed into features. Conditioned features, which contain frequency components specific to glucose or the other analytes, are derived from one or more features by modulating a carrier kernel with the feature. The conditioned features are computationally collided with one or more Zyotons that are co-dependent with the conditioned features. One or more collisions amplify a property of the analyte e.g., energy absorbed by glucose in tissue from radiation directed to the skin. A gradient of several values of the amplified property, each value corresponding to a particular radiation pattern according to a spectroscopic tomographic sequence, is used to select a suitable projector curve, with which a representative amplified value is projected to an accurate estimate of the concentration of glucose or the other analytes, without needing personalized calibration.
    Type: Application
    Filed: September 29, 2015
    Publication date: April 7, 2016
    Inventors: Sandeep Gulati, Timothy L. Ruchti, William V. Antwerp, John L. Smith
  • Patent number: 9240002
    Abstract: This disclosure describes systems and methods for a graphical interface including a graphical representation of medical data. The graphical interface platform may receive medical data and provide medical safety reporting capabilities including reporting of history data and real-time visual monitoring data. The graphical interface platform may be configured to identify potential problems and corrections to medical devices in operation while a reporting cycle is underway through visual representation of performance metrics.
    Type: Grant
    Filed: August 17, 2012
    Date of Patent: January 19, 2016
    Assignee: Hospira, Inc.
    Inventors: James A. Hume, Robert M. Hume, Robert Mayer, Devy Amy Lee, Gabriele Ott, Candida Arvelo, Timothy L. Ruchti, Tamas Ban, Mohammad M. Khair, Nancy H. Hedlund
  • Publication number: 20150359966
    Abstract: A system and method for monitoring and delivering medication to a patient. The system includes a controller that has a control algorithm and a closed loop control that monitors the control algorithm. A sensor is in communication with the controller and monitors a medical condition. A rule based application in the controller receives data from the sensor and the closed loop control and compares the data to predetermined medical information to determine the risk of automation of therapy to the patient. A system monitor is also in communication with the controller to monitor system, remote system, and network activity and conditions. The controller then provides a predetermined risk threshold where below the predetermined risk threshold automated closed loop medication therapy is provided. If the predetermined risk threshold is met or exceeded, automated therapy adjustments may not occur and user/clinician intervention is requested.
    Type: Application
    Filed: June 15, 2015
    Publication date: December 17, 2015
    Inventors: William Kenneth Day, Timothy L. Ruchti
  • Patent number: 9114217
    Abstract: An infusion system includes a pump, a fluid delivery line, a sensor, a processor, and a memory. The fluid delivery line is connected to the pump for delivering fluid. The sensor is connected to the fluid delivery line for emitting and receiving signals to detect whether there is air in the fluid delivery line. The processor is in electronic communication with the pump and the sensor. The memory is in electronic communication with the processor. The memory includes programming code for execution by the processor. The programming code is configured to analyze the signals to determine if a stuck fluid droplet is stuck within the fluid delivery line at a location of the sensor.
    Type: Grant
    Filed: August 17, 2012
    Date of Patent: August 25, 2015
    Assignee: Hospira, Inc.
    Inventors: Kunal Sur, Paul T. Kotnik, Anatoly S. Belkin, John Hicks Dumas, III, Timothy L. Ruchti
  • Publication number: 20150141955
    Abstract: An infusion pump automation system and method includes an infusion pump, an infusion pump and a remote processor. The remote processor is remote to the infusion pump and includes a controller interface and a controller, such that the controller bidirectionally communicates with the infusion pump, determines a current infusion state of the infusion pump and a current infusion pump user interface state and accepts a command to change the infusion state of the infusion pump from an external server. The controller determines if the command is consistent with the current infusion state of the infusion pump and the current infusion pump user interface state, executes the command if the command is able to be successfully executed, and confirms that the command is successfully executed.
    Type: Application
    Filed: November 19, 2014
    Publication date: May 21, 2015
    Inventors: Timothy L. Ruchti, Harsh Dharwad, Lynn D. Neuhardt, Aaron P. Perez
  • Publication number: 20140358081
    Abstract: To detect air in a fluid delivery line of an infusion system, infusion fluid is pumped through a fluid delivery line adjacent to at least one sensor. A signal is transmitted and received using the at least one sensor into and from the fluid delivery line. The at least one sensor is operated, using at least one processor, at a modified frequency which is different than a resonant frequency of the at least one sensor to reduce an amplitude of an output of the signal transmitted from the at least one sensor to a level which is lower than a saturation level of the analog-to-digital converter to avoid over-saturating the analog-to-digital converter. The signal received by the at least one sensor is converted from analog to digital using an analog-to-digital converter. The at least one processor determines whether air is in the fluid delivery line based on the converted digital signal.
    Type: Application
    Filed: May 29, 2014
    Publication date: December 4, 2014
    Inventors: John H. Dumas, III, Paul T. Kotnik, Kunal Sur, Anatoly S. Belkin, Timothy L. Ruchti
  • Publication number: 20140358077
    Abstract: In one step of a method for infusing an infusion fluid, the infusion fluid is pumped through a fluid delivery line of an infusion system. In another step, measurements are taken with at least one sensor connected to the infusion system. In an additional step, an air determination is determined with at least one processor. The air determination is related to air in the fluid delivery line. The air determination is based on the measurements taken by the at least one sensor. The air determination is further based on: (1) medication information regarding the infusion fluid or infusion information regarding the infusion of the infusion fluid; or (2) multi-channel filtering of the measurements from the at least one sensor or non-linear mapping of the measurements from the at least one sensor; and statistical process control charts applied to the multi-channel filtered measurements or applied to the non-linear mapped measurements.
    Type: Application
    Filed: May 29, 2014
    Publication date: December 4, 2014
    Inventors: MERIYAN ORUKLU, TIMOTHY L. RUCHTI, PAUL T. KOTNIK, ANATOLY S. BELKIN
  • Publication number: 20140350513
    Abstract: An infusion system for being operatively connected to a fluid delivery line and to an infusion container includes a pump, a plurality of different types of sensors connected to the pump or the fluid delivery line, at least one processor, and a memory. The plurality of different types of sensors are configured to indicate whether air is in the fluid delivery line. The memory includes programming code for execution by the at least one processor. The programming code is configured to, based on measurements taken by the plurality of different types of sensors, determine: whether there is air in the fluid delivery line; whether there is a partial occlusion or a total occlusion in the fluid delivery line; or a percentage of the air present in the fluid delivery line or the probability of the air being in the fluid delivery line.
    Type: Application
    Filed: May 23, 2014
    Publication date: November 27, 2014
    Inventors: Meriyan Oruklu, Timothy L. Ruchti, Paul T. Kotnik, Anatoly S. Belkin, Brian G. Markey
  • Patent number: 8868147
    Abstract: The invention relates generally to a probe interface method and apparatus for use in conjunction with an optical based noninvasive analyzer. More particularly, an algorithm controls a sample probe position and attitude relative to a skin sample site before and/or during sampling. For example, a sample probe head of a sample module is controlled by an algorithm along the normal-to-skin-axis. Preferably, the sample probe head is positioned in terms of 3-D location in the x-, y-, and z-axes and is attitude orientated in terms of pitch, yaw, and roll. Further, attitude of the probe head is preferably orientated prior to contact of the sample probe head with the tissue sample using indicators, such as non-contact distance feedback from capacitance sensor, contacting or non-contacting optical sensors, and/or contact electrical sensors.
    Type: Grant
    Filed: May 21, 2008
    Date of Patent: October 21, 2014
    Assignee: GLT Acquisition Corp.
    Inventors: Timothy W. Stippick, Thomas B. Blank, Timothy L. Ruchti, Christopher Slawinski
  • Publication number: 20130261993
    Abstract: Various systems and methods for detecting air in a chamber of an infusion system are disclosed. In one embodiment, a determination is made that air is contained in the chamber on the basis of a change in the average force exerted against the plunger utilizing a derivative spike for event detection and a systematic reduction in the average force to confirm the nature of the change. In another embodiment, a determination is made that the chamber contains air when a difference between the current force profile and a baseline force profile crosses a threshold. In an additional embodiment, a force profile is classified as being an air force profile or a liquid force profile based on extracted features of the force profile.
    Type: Application
    Filed: March 27, 2013
    Publication date: October 3, 2013
    Inventors: Timothy L. Ruchti, Brian G. Markey, Anatoly S. Belkin, Paul T. Kotnik, Mohammed M. Khair
  • Patent number: 8504128
    Abstract: Sampling is controlled in order to enhance analyte concentration estimation derived from noninvasive sampling. More particularly, sampling is controlled using controlled fluid delivery to a region between a tip of a sample probe and a tissue measurement site. The controlled fluid delivery enhances coverage of a skin sample site with the thin layer of fluid. Delivery of contact fluid is controlled in terms of spatial delivery, volume, thickness, distribution, temperature, and/or pressure.
    Type: Grant
    Filed: April 24, 2008
    Date of Patent: August 6, 2013
    Assignee: GLT Acquisition Corp.
    Inventors: Thomas B. Blank, Stephen L. Monfre, Kevin H. Hazen, Timothy L. Ruchti, Christopher Slawinski, Sedar R. Brown
  • Publication number: 20130158504
    Abstract: A system and method for monitoring and delivering medication to a patient includes a controller that has a control algorithm and a closed loop control that monitors the control algorithm. A sensor is in communication with the controller and monitors a medical condition. A rule base application in the controller receives data from the sensor and the closed loop control and compares the data to predetermined medical information to determine the risk of automation of therapy to the patient. The controller then provides a predetermined risk threshold where below the predetermined risk threshold automated closed loop medication therapy is provided. If the predetermined risk threshold is met or exceeded, automated therapy adjustments may not occur and user/clinician intervention is requested.
    Type: Application
    Filed: December 14, 2012
    Publication date: June 20, 2013
    Inventors: Timothy L. Ruchti, Mohammad M. Khair
  • Publication number: 20130085689
    Abstract: An infusion system includes a pump, a fluid delivery line, at least one sensor, a processor, and a memory. The fluid delivery line is connected to the pump for delivering fluid. The at least one sensor is connected to the fluid delivery line for emitting and receiving signals to detect whether there is air in the fluid delivery line. The processor is in electronic communication with the pump and the at least one sensor. The memory is in electronic communication with the processor. The memory comprises programming code for execution by the processor. The programming code is configured to determine a percentage of the air within an observed volume of the fluid delivery line.
    Type: Application
    Filed: September 28, 2012
    Publication date: April 4, 2013
    Inventors: Kunal Sur, Paul T. Kotnik, Anatoly S. Belkin, John Hicks Dumas, III, Timothy L. Ruchti
  • Publication number: 20130047113
    Abstract: This disclosure describes systems and methods for a graphical interface including a graphical representation of medical data. The graphical interface platform may receive medical data and provide medical safety reporting capabilities including reporting of history data and real-time visual monitoring data. The graphical interface platform may be configured to identify potential problems and corrections to medical devices in operation while a reporting cycle is underway through visual representation of performance metrics.
    Type: Application
    Filed: August 17, 2012
    Publication date: February 21, 2013
    Inventors: Robert Mayer, Devy Amy Lee, Gabriele Ott, Candida Arvelo, Timothy L. Ruchti, Tamas Ban, Mohammad M. Khair, Nancy H. Hedlund, Robert M. Hume
  • Publication number: 20130046508
    Abstract: An infusion system includes a pump, a fluid delivery line, a sensor, a processor, and a memory. The fluid delivery line is connected to the pump for delivering fluid. The sensor is connected to the fluid delivery line for emitting and receiving signals to detect whether there is air in the fluid delivery line. The processor is in electronic communication with the pump and the sensor. The memory is in electronic communication with the processor. The memory includes programming code for execution by the processor. The programming code is configured to analyze the signals to determine if a stuck fluid droplet is stuck within the fluid delivery line at a location of the sensor.
    Type: Application
    Filed: August 17, 2012
    Publication date: February 21, 2013
    Inventors: Kunal Sur, Paul T. Kotnik, Anatoly S. Belkin, John Hicks Dumas, III, Timothy L. Ruchti
  • Publication number: 20120310152
    Abstract: A system and method to configure a rule set used in connection with a medical monitoring system for monitoring patients and patient care equipment, especially medication delivery pumps, based on a variety of conditions and parameters associated with monitored biometric information and equipment information and for providing user-defined responses to those conditions and parameters.
    Type: Application
    Filed: August 15, 2012
    Publication date: December 6, 2012
    Applicant: Hospira, Inc.
    Inventors: Steven R. Wehba, Timothy L. Ruchti
  • Patent number: 8271106
    Abstract: A system and method to configure a rule set used in connection with a medical monitoring system for monitoring patients and patient care equipment, especially medication delivery pumps, based on a variety of conditions and parameters associated with monitored biometric information and equipment information and for providing user-defined responses to those conditions and parameters.
    Type: Grant
    Filed: April 15, 2010
    Date of Patent: September 18, 2012
    Assignee: Hospira, Inc.
    Inventors: Steven R. Wehba, Timothy L. Ruchti